Point72 Asset Management
BBNX

Point72 Asset Management’s Beta Bionics BBNX Stock Holding History

Point72 Asset Management’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$25.3M Buy
2,525,040
+1,537,689
+156% +$22.7M 0.03% 684
2025
Q4 		$30.1M Buy
+987,351
New +$26.4M 0.03% 654
2025
Q2 		– Sell
-364,329
Closed -$4.46M – 2676
2025
Q1 		$4.46M Buy
+364,329
New +$6.79M 0.01% 963

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Point72 Asset Management's BBNX Position: Q1 2026 in Review

Point72 Asset Management increased its Beta Bionics (BBNX) stake by 156% in Q1 2026, buying an estimated $22.7M and bringing the position to 2,525,040 shares worth $25.3M. The position accounts for 0.03% of the portfolio, ranked #684.

Point72 Asset Management first reported a position in BBNX in Q1 2025 and has held it in 3 quarters since. The position peaked at $30.1M in Q4 2025. 130 funds tracked by Wall St. Rank hold BBNX as of Q1 2026.

  • Point72 Asset Management held 2,525,040 shares of Beta Bionics worth $25.3M as of Q1 2026.
  • Point72 Asset Management bought 1,537,689 Beta Bionics shares in Q1 2026, an estimated $22.7M.
  • Beta Bionics made up 0.03% of Point72 Asset Management's portfolio in Q1 2026, its #684 holding.
  • Point72 Asset Management first reported a position in Beta Bionics in Q1 2025 and has held it in 3 quarters since.
  • Point72 Asset Management's Beta Bionics position peaked at $30.1M in Q4 2025.
  • 130 funds tracked by Wall St. Rank held Beta Bionics as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.